Latest Drug Approvals news
FDA Approves Twice-Yearly Yeztugo for Preexposure Prophylaxis to Cut HIV Risk
posted June 20th
by modernClinician Editorial Team
by modernClinician Editorial Team
Eli Lilly to Buy Gene Therapy Firm Verve in $1 Billion Deal to Develop Heart Drug
posted June 18th
by modernClinician Editorial Team
by modernClinician Editorial Team
FDA Offers Speedier Approvals to Drug Companies Aligning With “National Priorities”
posted June 18th
by modernClinician Editorial Team
by modernClinician Editorial Team
Agency is offering vouchers to some drug manufacturers to shorten review time for final drug applications
Texas Invests $50M in Psychedelic Drug Research to Treat Addiction
posted June 16th
by modernClinician Editorial Team
by modernClinician Editorial Team
Editor's Recommendations
Homicide, Suicide, and Overdose Leading Causes of Maternal Death 
Model Predicts Poor Outcomes Within 30 Days of a Before Medically Advised Discharge 
Countries Involved in U.S. Clinical Trials Do Not Gain Timely Access to Approved Medicines Related Articles
FDA Picks George Tidmarsh to Head Center for Drug Evaluation and Research 
Approved-Label Populations for New Drugs Broader Than Trial Populations 
FDA Expands Indication of Dust Mite Allergy Drug to Include Young Children 
Time From Drug Approval to Reimbursement Longer in U.S. Than Some European Countries Monthly Specialist Briefings
Stay Connected
